[Neonatal hepatitis. II. Follow-up studies].
D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006505:Hepatitis / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology / Q000473:pathology; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000097:blood / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology / Q000473:pathology; D007931:Leucyl Aminopeptidase / Q000097:blood; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000209:etiology; D008111:Liver Function Tests; D008297:Male; D011379:Prognosis; D013163:Splenomegaly / Q000209:etiology; D013448:Sulfobromophthalein; D000637:Transaminases / Q000097:blood
D013448:Sulfobromophthalein; D002784:Cholesterol; D000637:Transaminases; D007931:Leucyl Aminopeptidase; D001663:Bilirubin
Neonatal Hepatitis. II. Katamnestische Untersuchungen.